• Top Stories
  • Interviews
  • Business
  • Finance
  • Banking
  • Technology
  • Investing
  • Trading
  • Videos
  • Awards
  • Magazines
  • Headlines
  • Trends
Close Search
00
GBAF LogoGBAF Logo
  • Top Stories
  • Interviews
  • Business
  • Finance
  • Banking
  • Technology
  • Investing
  • Trading
  • Videos
  • Awards
  • Magazines
  • Headlines
  • Trends
GBAF Logo
  • Top Stories
  • Interviews
  • Business
  • Finance
  • Banking
  • Technology
  • Investing
  • Trading
  • Videos
  • Awards
  • Magazines
  • Headlines
  • Trends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking and Finance Review

Global Banking & Finance Review

Company

    GBAF Logo
    • About Us
    • Profile
    • Wealth
    • Privacy & Cookie Policy
    • Terms of Use
    • Contact Us
    • Advertising
    • Submit Post
    • Latest News
    • Research Reports
    • Press Release

    Global Banking & Finance Review® is a leading financial portal and online magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management.
    Copyright © 2010-2025 GBAF Publications Ltd - All Rights Reserved.

    ;
    Editorial & Advertiser disclosure

    Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    Top Stories

    Posted By Jessica Weisman-Pitts

    Posted on December 8, 2021

    Featured image for article about Top Stories

    By Bansari Mayur Kamdar and Shashank Nayar

    (Reuters) -UK’s main stock indexes gained on Wednesday after hitting session lows as positive headlines on COVID-19 vaccines helped offset concerns about Britain implementing tougher COVID-19 measures as early as Thursday.

    The blue-chip FTSE 100 turned negative before rising 0.2% as a fall in sterling to fresh 2021 lows boosted the exporter-heavy index. [GBP/]

    Several media reports said Prime Minister Boris Johnson might announce as soon as Wednesday a new coronavirus Plan B which could include advice to work from home and COVID passports for large venues.

    However, markets were quick to reverse losses after BioNTech and Pfizer said that a three-shot course of their COVID-19 vaccine showed a neutralising effect against the new Omicron variant in a laboratory test.

    “The Pfizer news is feeding into that more positive picture that’s being built around Omicron,” said Craig Erlam, senior market analyst at Oanda.

    “This idea is that it’s not all doom and gloom, just because this variant is more vaccine resistant, it doesn’t mean the vaccines are now useless, is building a more positive picture than what we were facing a week last Friday,” Erlam added.

    The mid-cap FTSE 250 index advanced 0.1%, but weakness in pub and restaurant stocks including Mitchells and Butlers, JD Wetherspoon and Restaurant Group, all down between 1.7% and 4.5%, limited further gains.

    Cineworld dropped 5.1% and was the top loser on the travel and leisure sub-index, while British airline stocks Wizz Air, Easyjet and British Airways owner IAG fall more than 3% each.

    UK’s benchmark FTSE 100 has rebounded to levels seen before the detection of the Omicron variant in late-November, as experts say the new strain might not be as severe as feared.

    Tour operator TUI declined 0.8% after it posted an annual loss of over 2 billion euros ($2.26 billion).

    Homebuilder Berkeley Group Holdings added 4.2% as it raised annual profit outlook after sales recovered to pre-pandemic levels.

    (Reporting by Bansari Mayur Kamdar in Bengaluru; Editing by Subhranshu Sahu, Uttaresh.V, William Maclean)

    By Bansari Mayur Kamdar and Shashank Nayar

    (Reuters) -UK’s main stock indexes gained on Wednesday after hitting session lows as positive headlines on COVID-19 vaccines helped offset concerns about Britain implementing tougher COVID-19 measures as early as Thursday.

    The blue-chip FTSE 100 turned negative before rising 0.2% as a fall in sterling to fresh 2021 lows boosted the exporter-heavy index. [GBP/]

    Several media reports said Prime Minister Boris Johnson might announce as soon as Wednesday a new coronavirus Plan B which could include advice to work from home and COVID passports for large venues.

    However, markets were quick to reverse losses after BioNTech and Pfizer said that a three-shot course of their COVID-19 vaccine showed a neutralising effect against the new Omicron variant in a laboratory test.

    “The Pfizer news is feeding into that more positive picture that’s being built around Omicron,” said Craig Erlam, senior market analyst at Oanda.

    “This idea is that it’s not all doom and gloom, just because this variant is more vaccine resistant, it doesn’t mean the vaccines are now useless, is building a more positive picture than what we were facing a week last Friday,” Erlam added.

    The mid-cap FTSE 250 index advanced 0.1%, but weakness in pub and restaurant stocks including Mitchells and Butlers, JD Wetherspoon and Restaurant Group, all down between 1.7% and 4.5%, limited further gains.

    Cineworld dropped 5.1% and was the top loser on the travel and leisure sub-index, while British airline stocks Wizz Air, Easyjet and British Airways owner IAG fall more than 3% each.

    UK’s benchmark FTSE 100 has rebounded to levels seen before the detection of the Omicron variant in late-November, as experts say the new strain might not be as severe as feared.

    Tour operator TUI declined 0.8% after it posted an annual loss of over 2 billion euros ($2.26 billion).

    Homebuilder Berkeley Group Holdings added 4.2% as it raised annual profit outlook after sales recovered to pre-pandemic levels.

    (Reporting by Bansari Mayur Kamdar in Bengaluru; Editing by Subhranshu Sahu, Uttaresh.V, William Maclean)

    Recommended for you

    • Thumbnail for recommended article

    • Thumbnail for recommended article

    • Thumbnail for recommended article

    Why waste money on news and opinions when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe